Profil
Elizabeth Yamashita worked as a Group Director-Global Regulatory Sciences & CMC at Bristol Myers Squibb Co. from 2000 to 2006.
She then worked as a Vice President-Regulatory CMC & Operations at ImClone LLC from 2006 to 2011.
From 2011 to 2012, she worked as a Vice President-CMC Regulatory at Savient Pharmaceuticals, Inc. She then worked as a Group Vice President-Regulatory Affairs at Savient Pharmaceuticals, Inc. from 2012 to 2014.
Finally, she worked as a Vice President-Regulatory Affairs at Outlook Therapeutics, Inc. Ms. Yamashita received an undergraduate degree from the University of Rochester.
Ehemalige bekannte Positionen von Elizabeth Yamashita
| Unternehmen | Position | Ende |
|---|---|---|
| SAVIENT PHARMACEUTICALS INC | Corporate Officer/Principal | 01.01.2014 |
| SAVIENT PHARMACEUTICALS INC | Corporate Officer/Principal | 01.10.2012 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Corporate Officer/Principal | 01.06.2011 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.2006 |
| OUTLOOK THERAPEUTICS, INC. | General Counsel | - |
Ausbildung von Elizabeth Yamashita
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Savient Pharmaceuticals, Inc.
Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products | Health Technology |
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Rochester Christian University
Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Outlook Therapeutics, Inc.
Outlook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bevacizumab therapeutic products | Health Technology |
















